From: Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial
Reason for stopping
Posterior probability
Decision rule
Effectiveness
Pr(OR < log(1.00)) > 0.975
> 0.95
Futility
< 0.02